| Lucy Day |
lda*@an2therapeutics.com
|
an2therapeutics.com |
Chief Financial Officer |
|
California, United States |
|
| Lynn Connolly |
lco******@an2therapeutics.com
|
an2therapeutics.com |
Senior Vice President of Clinical Development |
|
Atherton, CA, US |
|
| Alex Smith |
asm***@an2therapeutics.com
|
an2therapeutics.com |
Vice President, Biostatistics |
|
San Francisco, CA, US |
|
| Joshua Eizen |
jei***@an2therapeutics.com
|
an2therapeutics.com |
Chief Legal Officer |
|
San Ramon, CA, US |
|
| Vince Hernandez |
vhe*******@an2therapeutics.com
|
an2therapeutics.com |
Vice President of Chemistry |
|
Palo Alto, CA, US |
|
| Alexander Tung |
atu**@an2therapeutics.com
|
an2therapeutics.com |
Vice President Quality Assurance |
|
California, United States |
|
| Jennifer Long |
jlo**@an2therapeutics.com
|
an2therapeutics.com |
Vice President, Data Management |
|
Oakland, CA, US |
|
| Serge Boyer |
sbo***@an2therapeutics.com
|
an2therapeutics.com |
Senior Director of Process Chemistry |
|
San Diego, California, United States |
|
| Preston Klassen |
pkl*****@regulusrx.com
|
Regulus Therapeutics |
President, Head of R&D |
Biotechnology Research |
San Diego, CA, US |
|
| www.linkedin.com › › Criscalsadacris Calsada |
w› *************************@regulusrx.com
|
Regulus Therapeutics |
|
Biotechnology Research |
San Diego, CA, US |
|